Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
• To evaluate the lung bioavailability of B17MP (active metabolite of BDP) and formoterol as AUC0-t across two different dose strengths of CHF 1535 NEXThaler DPI (100/6 µg, 200/6 µg) with activated charcoal. • To evaluate the total systemic exposure to B17MP (active metabolite of BDP) and to Formoterol as AUC0-t across two different dose strengths of CHF 1535 NEXThaler DPI (100/6 µg, 200/6 µg) without activated charcoal.
Critère d'inclusion
- Asthma